Cytek Biosciences Inc (NAS:CTKB)
$ 6.39 -0.14 (-2.14%) Market Cap: 841.13 Mil Enterprise Value: 572.72 Mil PE Ratio: 0 PB Ratio: 2.20 GF Score: 60/100

Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2021 / 09:00PM GMT
Release Date Price: $26.78 (+2.57%)
Edmund Tu
Morgan Stanley - Analyst

Good afternoon, everyone. Thank you for joining us on day four of the Morgan Stanley global healthcare conference. My name is Edmund Tu and I'm on the life science tools and diagnostics team here at Morgan Stanley.

I'm very excited to have with me today Cytek Biosciences. And representing the company, I have Dr. Wenbin Jiang, CEO, and Mr. Patrik Jeanmonod, CFO. Thank you, guys, for joining today.

Patrik Jeanmonod
Cytek Biosciences, Inc. - CFO

Good morning.

Wenbin Jiang
Cytek Biosciences, Inc. - Chairman and CEO

Good afternoon.

Edmund Tu
Morgan Stanley - Analyst

Before we began, I just want to make two quick comments. You can find important research disclosures on our website at morganstanley.com/research disclosures. And if you have any additional questions, please reach out to your Morgan Stanley sales representative. (Conference Instructions)

And with that, welcome, guys. Thank you for joining us today. Welcome

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot